Sclerostin as a Genetic Determinant of Trabecular Bone Score in Postmenopausal Women: The Bushehr Elderly Health (BEH) Program
<i>SOST</i> gene is associated with TBS and may have implications for personalized medicine. Targeting sclerostin through <i>SOST</i> could offer a therapeutic approach in managing osteoporosis in high-risk postmenopausal women.
Authors
- Bagher Larijani (ORCID: https://orcid.org/0000-0001-5386-7597)
- Noushin Fahimfar (ORCID: https://orcid.org/0000-0001-6205-9794)
- Mohammad Bidkhori (ORCID: https://orcid.org/0000-0002-0965-3679)
- Mahdi Akbarzadeh (ORCID: https://orcid.org/0000-0002-8048-744X)
- Afshin Ostovar (ORCID: https://orcid.org/0000-0001-8670-5797)
- Iraj Nabipour (ORCID: https://orcid.org/0000-0002-1785-0883)
- Sepideh Hajivalizadeh (ORCID: https://orcid.org/0000-0003-0393-1196)
- Kourosh Holakouie-Naieni
- Reihane Seifi Moroudi
Institutions
- Biotechnology Research Center (IR)
- Research Institute for Endocrine Sciences (IR)
- Bushehr University of Medical Sciences (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Iranian Journal of Public Health
- Published
- 2024-10-19
- DOI
- https://doi.org/10.18502/ijph.v53i10.16724
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00